MedPath
NMPA Approval

Rivastigmine Transdermal Patch

国药准字H20244948

September 19, 2024

Drug Information

利斯的明透皮贴剂

贴剂

9.5mg/24小时

化学药品

September 19, 2024

Company Information

Applicant Company

北京市北京经济技术开发区荣京东街8号

Manufacturing Company

北京市北京经济技术开发区荣京东街8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利斯的明透皮贴剂 - NMPA 批准文号 | MedPath